161TiP 一项针对晚期实体瘤患者的抗 ILT2 (LILRB1) 抗体 SAR444881 单药或与 pembrolizumab（无论有无化疗）或西妥昔单抗联合用药的 I/II 期开放标签研究

{"title":"161TiP 一项针对晚期实体瘤患者的抗 ILT2 (LILRB1) 抗体 SAR444881 单药或与 pembrolizumab（无论有无化疗）或西妥昔单抗联合用药的 I/II 期开放标签研究","authors":"R. Perets, S. Stemmer, R. Geva, T. Golan, M. Fakih, J. Cohen, C. Lieu, Z. Jin, P. Lorusso, N. Ashtamker, I. Friedman, M. Hakim, N. Crawford, R. Perez, M. Agarwal, G. Abbadessa, M. Wu, J. Lin, C. Deantonio, M. Borad","doi":"10.1016/j.iotech.2023.100672","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"79 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"161TiP A phase I/II, open-label study of an anti-ILT2 (LILRB1) antibody, SAR444881, administered alone and in combination with pembrolizumab, with or without chemotherapy, or cetuximab in patients with advanced solid tumors\",\"authors\":\"R. Perets, S. Stemmer, R. Geva, T. Golan, M. Fakih, J. Cohen, C. Lieu, Z. Jin, P. Lorusso, N. Ashtamker, I. Friedman, M. Hakim, N. Crawford, R. Perez, M. Agarwal, G. Abbadessa, M. Wu, J. Lin, C. Deantonio, M. Borad\",\"doi\":\"10.1016/j.iotech.2023.100672\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":192507,\"journal\":{\"name\":\"Immuno-Oncology and Technology\",\"volume\":\"79 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Oncology and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.iotech.2023.100672\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100672","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}